Dysfunctional Uterine Bleeding Market Research Report - forecast till 2027

Dysfunctional Uterine Bleeding Market Information: By Type (Ovulatory), Diagnosis (Hysteroscopy, Ultrasonography), Treatment (Pharmacologic Treatment, Hysterectomy, Endometrial Ablation), End User (Diagnostic Centers) - Forecast Till 2027

ID: MRFR/Pharma/3264-HCR | February 2021 | Region: Global | 110 pages

Dysfunctional Uterine Bleeding Market Overview

Dysfunctional uterine bleeding, also known as abnormal uterine bleeding, is irregular bleeding occurring in the absence of any recognizable pelvic pathology. Pregnancy is a common cause of abnormal uterine bleeding. The main causes of uterine bleeding can be fibroids in the uterus, infection of the cervix, and cancer of the uterus in some cases. Medications causing dysfunctional uterine bleeding are birth control pills, hormonal agents, and Coumadin.


Rising prevalence of uterine disorders such as uterine cancer, polycystic ovary syndrome, endometriosis, and uterine polyps drive the dysfunctional uterine bleeding market growth. Furthermore, rising prevalence of uterine cancer, and demand for diagnosis and treatment measures also influence the dysfunctional uterine bleeding market growth. According to the Cancer Research, in 2014, 9324 new cases of uterine cancer were diagnosed in U.K and the number is expected to increase in the near future.


According to the World Cancer Research Fund International, endometrial cancer is the sixth most common cancer in women worldwide, with 320,000 new cases diagnosed in 2012. It also stated that about 53% of endometrial cancer cases occurred in the developed countries.


The dysfunctional uterine bleeding market is expected to grow at a CAGR of 8.2% during the forecast period.

FIGURE 1: Global Dysfunctional Uterine Bleeding Market by Region, 2016 (%)


 Dysfunctional Uterine Bleeding Market


U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


 Key Players in the Dysfunctional Uterine Bleeding Market        


Some of the key players in dysfunctional uterine bleeding market are B. Braun Melsungen AG (Germany), Hologic Inc. (U.S.), Karl Storz Gmbh & Co. KG (Germany), Medgyn Products, Inc., Olympus (Japan), Richard Wolf GmbH (Germany), Stryker (U.S.), Xion Medical GmbH (Germany), Cadila Pharmaceuticals Ltd. (India), Torrent Phamraceuticals (India).


Segments                                                                                                                                            


The dysfunctional uterine bleeding market is segmented on the basis of type, diagnosis, treatment, and end user.


On the basis of type, dysfunctional uterine bleeding market is segmented into ovulatory, and anovulatory.


On the basis of diagnosis, the dysfunctional uterine bleeding market is segmented into hysteroscopy, ultrasonography, dilation and curettage, endometrial biopsy, and others.


On the basis of treatment, the dysfunctional uterine bleeding market is segmented into pharmacologic treatment, hysterectomy, endometrial ablation, and others. The pharmacologic treatment includes oral contraceptives, estrogen, progestins, desmopressin and others.


On the basis of end user, the dysfunctional uterine bleeding market is segmented into hospitals, clinics, diagnostic centers, pharmaceutical companies, and others.


Research Methodology
Global Dysfunctional Uterine Bleeding Market

Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Regional Analysis of the Global Dysfunctional Uterine Bleeding Market                      


America is the largest market for dysfunctional uterine bleeding market across the globe. The dysfunctional uterine bleeding market is driven by the rising prevalence of uterine cancer and other uterine disorders among women. According to the American Cancer Institute, about 61,380 new cases of uterine cancer is estimated to be diagnosed in 2017.


Europe is the second largest market owing to an increasing demand for diagnosis and treatment measures for uterine cancer, fibroids and other disorders, and increasing emphasis on women healthcare.


The market in Asia Pacific is expected to grow at the fastest pace and is driven by the increasing prevalence of menstrual disorders, rising awareness about causes of such disorders and early diagnosis and treatment measures among women. The market is also driven by rising prevalence of sexually transmitted diseases among women in the developing nations.


The Middle East & Africa also show a steady rise in the market owing to increasing focus on women and child health, and need of primary care services in developing regions.


Intended Audience



  • Drug Manufacturers

  • Drug Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   8.2% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Diagnosis, Treatment, and End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   B. Braun Melsungen AG (Germany), Hologic Inc. (U.S.), Karl Storz Gmbh & Co. KG (Germany), Medgyn Products, Inc., Olympus (Japan), Richard Wolf GmbH (Germany), Stryker (U.S.), Xion Medical GmbH (Germany), Cadila Pharmaceuticals Ltd. (India), Torrent Phamraceuticals (India)
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Rising prevalence of uterine disorders
  • Rising prevalence of uterine cancer
  • Demand for diagnosis and treatment measures


  • Table of Content

    1. Report Prologue

    2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary research

    3.4 Market Size Estimation

    4. Market Dynamics

    4.1 Drivers

    4.2 Restrains

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    5. Market Factor Analysis

    5.1 Porters Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    6. Global Dysfunctional Uterine Bleeding Market, by Type

    6.1 Introduction

    6.2 Ovulatory

    6.2.1 Market Estimates & Forecast, 2020-2027

    6.3 Anovulastory

    6.3.1 Market Estimates & Forecast, 2020-2027

    7. Global Dysfunctional Uterine Bleeding Market, by Diagnosis

    7.1 Introduction

    7.2 hysteroscopy

    7.2.1 Market Estimates & Forecast, 2020-2027

    7.3 Ultrasonography

    7.3.1 Market Estimates & Forecast, 2020-2027

    7.4 Dilation and curettage

    7.4.1 Market Estimates & Forecast, 2020-2027

    7.5 endometrial biopsy

    7.5.1 Market Estimates & Forecast, 2020-2027

    8. Global Dysfunctional Uterine Bleeding Market, by Treatment

    8.1 Introduction

    8.2 Pharmacologic treatment

    8.2.1 Market Estimates & Forecast, 2020-2027

    8.3 Hysterectomy

    8.3.1 Market Estimates & Forecast, 2020-2027

    8.4 Endometrial ablation

    8.4.1 Market Estimates & Forecast, 2020-2027

    9. Global Dysfunctional Uterine Bleeding Market, by End User

    9.1 Introduction

    9.2 Hospital

    9.2.1 Market Estimates & Forecast, 2020-2027

    9.3 Clinics

    9.3.1 Market Estimates & Forecast, 2020-2027

    9.4 Diagnostic Centers

    9.4.1 Market Estimates & Forecast, 2020-2027

    9.5 Pharmaceutical Companies

    9.5.1 Market Estimates & Forecast, 2020-2027

    10. Global Dysfunctional Uterine Bleeding Market, by Region

    10.1 Introduction

    10.2 Americas

    10.2.1 North America

    10.2.1.1 US

    10.2.1.1 Canada

    10.2.2 South America

    10.3 Europe

    10.3.1 Western Europe

    10.3.1.1 Germany

    10.3.1.2 France

    10.3.1.3 UK

    10.3.1.4 Italy

    10.3.1.5 Spain

    10.3.1.6 Rest of Western Europe

    10.3.2 Eastern Europe

    10.4 Asia Pacific

    10.4.1 Japan

    10.4.2 China

    10.4.3 India

    10.4.4 Australia

    10.4.5 Republic of Korea

    10.4.6 Rest of Asia Pacific

    10.5 The Middle East & Africa

    10.5.1 United Arab Emirates

    10.5.2 Saudi Arabia

    10.5.3 Oman

    10.5.4 Kuwait

    10.5.5 Qatar

    10.5.6 Rest of the Middle East & Africa

    11 Company Landscape

    11.1 Introduction

    11.2 Market Share Analysis

    11.3 Key Development & Strategies

    11.3.1 Key Developments

    12 Company Profiles

    12.1 B. BRAUN MELSUNGEN AG

    12.1.1 Company Overview

    12.1.2 Product Overview

    12.1.3 Financials

    12.1.4 SWOT Analysis

    12.2 Hologic Inc.

    12.2.1 Company Overview

    12.2.2 Product Overview

    12.2.3 Financial Overview

    12.2.4 Key Developments

    12.2.5 SWOT Analysis

    12.3 KARL STORZ GMBH & CO. KG

    12.3.1 Company Overview

    12.3.2 Product Overview

    12.3.3 Financial Overview

    12.3.4 Key Development

    12.3.5 SWOT Analysis

    12.4 Medgyn Products, Inc.

    12.4.1 Company Overview

    12.4.2 Product/Business Segment Overview

    12.4.3 Financial Overview

    12.4.4 Key Development

    12.4.5 SWOT Analysis

    12.5 Stryker

    12.5.1 Company Overview

    12.5.2 Product Overview

    12.5.3 Financial overview

    12.5.4 Key Developments

    12.6 Richard Wolf GmbH

    12.6.1 Company Overview

    12.6.2 Product Overview

    12.6.3 Financial Overview

    12.6.4 Key Developments

    12.7 Xion Medical GmbH

    12.7.1 Overview

    12.7.2 Product Overview

    12.7.3 Financials

    12.7.4 Key Developments

    12.7.5 SWOT Analysis

    12.8 Olympus

    12.8.1 Overview

    12.8.2 Product Overview

    12.8.3 Financials

    12.8.4 Key Developments

    12.8.5 SWOT Analysis

    12.9 Others

    13 MRFR Conclusion

    13.1 Key Findings

    13.1.1 From CEO’s View Point

    13.1.2 Unmet Needs of the Market

    13.2 Key Companies to Watch

    13.3 Prediction of Women Healthcare Industry

    14 Appendix

    LIST OF TABLES

    Table 1 Dysfunctional Uterine Bleeding Industry Synopsis, 2020-2027

    Table 2 Global Dysfunctional Uterine Bleeding Market Estimates and Forecast, 2020-2027, (USD Million)

    Table 3 Global Dysfunctional Uterine Bleeding Market by Region, 2020-2027, (USD Million)

    Table 4 Global Dysfunctional Uterine Bleeding Market by Types, 2020-2027, (USD Million)

    Table 5 Global Dysfunctional Uterine Bleeding Market by Diagnosis, 2020-2027, (USD Million)

    Table 6 Global Dysfunctional Uterine Bleeding Market by Treatment, 2020-2027, (USD Million)

    Table 7 Global Dysfunctional Uterine Bleeding Market by End Users, 2020-2027, (USD Million)

    Table 8 North America Dysfunctional Uterine Bleeding Market by Types, 2020-2027, (USD Million)

    Table 9 North America Dysfunctional Uterine Bleeding Market by Diagnosis, 2020-2027, (USD Million)

    Table 10 North America Dysfunctional Uterine Bleeding Market by Treatment, 2020-2027, (USD Million)

    Table 11 North America Dysfunctional Uterine Bleeding Market by End Users, 2020-2027, (USD Million)

    Table 12 US Dysfunctional Uterine Bleeding Market by Types, 2020-2027, (USD Million)

    Table 13 US Dysfunctional Uterine Bleeding Market by Diagnosis, 2020-2027, (USD Million)

    Table 14 US Dysfunctional Uterine Bleeding Market by Treatment, 2020-2027, (USD Million)

    Table 15 US Dysfunctional Uterine Bleeding Market by End Users, 2020-2027, (USD Million)

    Table 16 Canada Dysfunctional Uterine Bleeding Market by Types, 2020-2027, (USD Million)

    Table 17 Canada Dysfunctional Uterine Bleeding Market by Diagnosis, 2020-2027, (USD Million)

    Table 18 Canada Dysfunctional Uterine Bleeding Market by Treatment, 2020-2027, (USD Million)

    Table 19 Canada Dysfunctional Uterine Bleeding Market by End Users, 2020-2027, (USD Million)

    Table 20 South America Dysfunctional Uterine Bleeding Market by Types, 2020-2027, (USD Million)

    Table 21 South America Dysfunctional Uterine Bleeding Market by Diagnosis, 2020-2027, (USD Million)

    Table 22 South America Dysfunctional Uterine Bleeding Market by Treatment, 2020-2027, (USD Million)

    Table 23 South America Dysfunctional Uterine Bleeding Market by End Users, 2020-2027, (USD Million)

    Table 24 Europe Dysfunctional Uterine Bleeding Market by Types, 2020-2027, (USD Million)

    Table 25 Europe Dysfunctional Uterine Bleeding Market by Diagnosis, 2020-2027, (USD Million)

    Table 26 Europe Dysfunctional Uterine Bleeding Market by Treatment, 2020-2027, (USD Million)

    Table 27 Europe Dysfunctional Uterine Bleeding Market by End Users, 2020-2027, (USD Million)

    Table 28 Western Europe Dysfunctional Uterine Bleeding Market by Types, 2020-2027, (USD Million)

    Table 29 Western Europe Dysfunctional Uterine Bleeding Market by Diagnosis, 2020-2027, (USD Million)

    Table 30 Western Europe Dysfunctional Uterine Bleeding Market by Treatment, 2020-2027, (USD Million)

    Table 31 Western Europe Dysfunctional Uterine Bleeding Market by End Users, 2020-2027, (USD Million)

    Table 32 Eastern Europe Dysfunctional Uterine Bleeding Market by Types, 2020-2027, (USD Million)

    Table 33 Eastern Europe Dysfunctional Uterine Bleeding Market by Diagnosis, 2020-2027, (USD Million)

    Table 34 Eastern Europe Dysfunctional Uterine Bleeding Market by Treatment, 2020-2027, (USD Million)

    Table 35 Eastern Europe Dysfunctional Uterine Bleeding Market by End Users, 2020-2027, (USD Million)

    Table 36 Asia Pacific Dysfunctional Uterine Bleeding Market by Types, 2020-2027, (USD Million)

    Table 37 Asia Pacific Dysfunctional Uterine Bleeding Market by Diagnosis, 2020-2027, (USD Million)

    Table 38 Asia Pacific Dysfunctional Uterine Bleeding Market by Treatment, 2020-2027, (USD Million)

    Table 39 Asia Pacific Dysfunctional Uterine Bleeding Market by End Users, 2020-2027, (USD Million)

    Table 40 Middle East & Africa Dysfunctional Uterine Bleeding Market by Types, 2020-2027, (USD Million)

    Table 41 Middle East & Africa Dysfunctional Uterine Bleeding Market by Diagnosis, 2020-2027, (USD Million)

    Table 42 Middle East & Africa Dysfunctional Uterine Bleeding Market by Treatment, 2020-2027, (USD Million)

    Table 43 Middle East & Africa Dysfunctional Uterine Bleeding Market by End Users, 2020-2027, (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Dysfunctional Uterine Bleeding Market

    Figure 3 Segmentation Market Dynamics for Dysfunctional Uterine Bleeding Market

    Figure 4 Global Dysfunctional Uterine Bleeding Market Share, by Diagnosis 2020

    Figure 5 Global Dysfunctional Uterine Bleeding Market Share, by Treatment 2020

    Figure 6 Global Dysfunctional Uterine Bleeding Market Share, by End Users, 2020

    Figure 7 Global Dysfunctional Uterine Bleeding Market Share, by Region, 2020

    Figure 8 North America Dysfunctional Uterine Bleeding Market Share, by Country, 2020

    Figure 9 Europe Dysfunctional Uterine Bleeding Market Share, by Country, 2020

    Figure 10 Asia Pacific Dysfunctional Uterine Bleeding Market Share, by Country, 2020

    Figure 11 Middle East & Africa Dysfunctional Uterine Bleeding Market Share, by Country, 2020

    Figure 12 Global Dysfunctional Uterine Bleeding Market: Company Share Analysis, 2020 (%)

    Figure 13 B. BRAUN MELSUNGEN AG: Key Financials

    Figure 14 B. BRAUN MELSUNGEN AG: Segmental Revenue

    Figure 16 B. BRAUN MELSUNGEN AG: Geographical Revenue

    Figure 17 Hologic Inc.: Key Financials

    Figure 18 Hologic Inc.: Segmental Revenue

    Figure 19 Hologic Inc.: Geographical Revenue

    Figure 20 KARL STORZ GMBH & CO. KG: Key Financials

    Figure 21 KARL STORZ GMBH & CO. KG: Segmental Revenue

    Figure 22 KARL STORZ GMBH & CO. KG: Geographical Revenue

    Figure 23 Medgyn Products, Inc.: Key Financials

    Figure 24 Medgyn Products, Inc.: Segmental Revenue

    Figure 25 Medgyn Products, Inc.: Geographical Revenue

    Figure 26 Richard Wolf GmbH : Key Financials

    Figure 27 Richard Wolf GmbH : Segmental Revenue

    Figure 28 Richard Wolf GmbH : Geographical Revenue

    Figure 29 Stryker: Key Financials

    Figure 30 Stryker: Segmental Revenue

    Figure 31 Stryker: Geographical Revenue

    Figure 32 Pfizer Inc: Key Financials

    Figure 33 Pfizer Inc: Segmental Revenue

    Figure 34 Pfizer Inc: Geographical Revenue